Mol Cancer Ther 6:789801
GLP-1 medications most commonly cause gastrointestinal symptoms (including nausea, constipation, and diarrhea)
However, in insulin-resistant states, cells in the liver, muscles, and adipose tissue fail to respond efficiently to insulin, leading to hyperglycemia, dyslipidemia, and metabolic stress
The results showed that GLP-1R agonist liraglutide treatment partially reversed the NTG-induced shortening of both total (100.45 40.55 m vs
There are also supplements that, although touted, do not seem to be beneficial
However, prolonged gastric retention also means delayed arrival at the intrinsic factor binding sites and the ileal absorption receptors